Multiple sclerosis (MS) is characterized by chronic inflammation leading to central nervous system demyelination. Almost 90% of people with MS have relapsing-remitting MS (RRMS) or secondary ...

Similarly, the therapy led to long-term reductions of severe symptoms of 91% and 100% for the smaller and larger doses, ...

This study is led by Professor Rong Hu's team from the Department of Neurosurgery and Key Laboratory of Neurotrama, Southwest Hospital, Third Military ...

Mapping cell types in MS lesions reveals unique tissue niches and interactions, offering insights into the molecular drivers of multiple sclerosis progression.

In a paper published in Science Bulletin, multi-omics analyses comprising of lipidomics (439 lipids), sterolomics (22 ...

Progressive Multifocal Leukoencephalopathy (PML) is a severe, life-threatening condition that poses a particular risk for MS ...

Multiple sclerosis, a neuroinflammatory disease that affects nearly 3 million people worldwide, causes a loss of myelin, the ...

Model developed in study will pave way for more discovery about important but mysterious process Ben Emery, Ph.D., and ...

New research has identified crucial links between dietary choices and the progression of multiple sclerosis (MS). The study explored how enzymes called ceramide synthase 5 and 6 are responsible for ...

Newly published research in the journal Glia has identified crucial links between dietary choices and the progression of multiple sclerosis (MS).

Multiple Sclerosis is an inflammatory autoimmune disease marked by extensive damage to the insulating myelin sheath that protects nerves throughout the body.

Using the experimental autoimmune encephalomyelitis (EAE) model of inflammatory demyelination, the research team found that ...